{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:50:04Z","timestamp":1793883004824,"version":"4.7.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.therap.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:59:07Z","timestamp":1716292747000},"page":"659-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-3952","authenticated-orcid":false,"given":"Olivier","family":"Maillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Bun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Laanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Verga-G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Gault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Estellat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernelle","family":"Noize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fourrier-R\u00e9glat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2024.05.003_bib0165","doi-asserted-by":"crossref","first-page":"e023090","DOI":"10.1136\/bmjopen-2018-023090","article-title":"Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation","volume":"8","author":"Pacurariu","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.therap.2024.05.003_bib0170","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/healthcare10071232","article-title":"Towards the use of big data in healthcare: a literature review","volume":"10","author":"Dicuonzo","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.therap.2024.05.003_bib0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/CLEP.S166545","article-title":"Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects","volume":"10","author":"Schneeweiss","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.05.003_bib0180","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/pds.5500","article-title":"Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: an overview of the current literature","volume":"31","author":"Wyss","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.1912","article-title":"Pharmacoepidemiological research using French reimbursement databases: yes we can!","volume":"19","author":"Martin-Latry","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0190","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/fcp.12214","article-title":"Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies","volume":"30","author":"Palmaro","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.therap.2024.05.003_bib0195","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.therap.2024.05.003_bib0200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2024.05.003_bib0205","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.therap.2018.09.072","article-title":"French administrative health care database (SNDS): the value of its enrichment","volume":"74","author":"Scailteux","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2024.05.003_bib0215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.revmed.2016.01.011","article-title":"Death certificate data in France: production process and main types of analyses","volume":"37","author":"Rey","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2024.05.003_bib0220","series-title":"The use of French medico-administrative databases for pharmacoepidemiology studies. PROSPERO","author":"Verga-Gerard","year":"2018"},{"key":"10.1016\/j.therap.2024.05.003_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.5537","article-title":"Core concepts in pharmacoepidemiology: validation of health outcomes of interest within real-world healthcare databases","volume":"32","author":"Weinstein","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.therap.2024.05.003_bib0235","unstructured":"Drug-related deaths and mortality in Europe: update from the EMCDDA expert network Luxembourg: Publications Office of the European Union; 2019. https:\/\/www.drugsandalcohol.ie\/30861\/. [Accessed 16 May 2024]"},{"key":"10.1016\/j.therap.2024.05.003_bib0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2183\/pjab.98.026","article-title":"Clinical epidemiology and pharmacoepidemiology studies with real-world databases","volume":"98","author":"Yoshida","year":"2022","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.therap.2024.05.003_bib0245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK general practice research database for pharmacoepidemiology","volume":"45","author":"Garc\u00eda Rodr\u00edguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2024.05.003_bib0250","doi-asserted-by":"crossref","first-page":"e00661","DOI":"10.1002\/prp2.661","article-title":"Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: a systematic review","volume":"8","author":"Franco","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.therap.2024.05.003_bib0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3896","article-title":"Systematic review of cross-national drug utilization studies in Latin America: methods and comparability","volume":"25","author":"Dur\u00e1n","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0260","series-title":"Databases for pharmacoepidemiological research","author":"Sturkenboom","year":"2021"},{"key":"10.1016\/j.therap.2024.05.003_bib0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2042098611435911","article-title":"Recent advances in the utility and use of the general practice research database as an example of a UK primary care data resource","volume":"3","author":"Williams","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00228-011-1088-2","article-title":"Utilization of health care databases for pharmacoepidemiology","volume":"68","author":"Takahashi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2024.05.003_bib0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40264-018-0732-5","article-title":"The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand?","volume":"42","author":"Trifir\u00f2","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pds.3457","article-title":"The Nordic prescription databases as a resource for pharmacoepidemiological research\u00a0\u2013\u00a0a literature review","volume":"22","author":"Wettermark","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.05.003_bib0285","doi-asserted-by":"crossref","first-page":"e018180","DOI":"10.1136\/bmjopen-2017-018180","article-title":"Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases","volume":"8","author":"Huiart","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.therap.2024.05.003_bib0290","doi-asserted-by":"crossref","first-page":"100226","DOI":"10.1016\/j.xjidi.2023.100226","article-title":"Concepts of designing and implementing pharmacoepidemiology studies on the safety of systemic treatments in dermatology practice","volume":"3","author":"Schneeweiss","year":"2023","journal-title":"JID Innov"},{"key":"10.1016\/j.therap.2024.05.003_bib0295","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/aje\/kwr001","article-title":"Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples","volume":"173","author":"Rassen","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.therap.2024.05.003_bib0300","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jama.2023.4221","article-title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.05.003_bib0305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/10543406.2020.1726371","article-title":"Innovative design and analysis for rare disease drug development","volume":"30","author":"Chow","year":"2020","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.therap.2024.05.003_bib0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12874-016-0278-0","article-title":"Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review","volume":"17","author":"Gault","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.therap.2024.05.003_bib0315","doi-asserted-by":"crossref","first-page":"e0226732","DOI":"10.1371\/journal.pone.0226732","article-title":"Estimating the impact of drug use on US mortality, 1999\u20132016","volume":"15","author":"Glei","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2024.05.003_bib0320","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T08:55:09Z","timestamp":1732352109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595724000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0040595724000659"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.05.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}